Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3792219rdf:typepubmed:Citationlld:pubmed
pubmed-article:3792219lifeskim:mentionsumls-concept:C0678222lld:lifeskim
pubmed-article:3792219lifeskim:mentionsumls-concept:C0019929lld:lifeskim
pubmed-article:3792219lifeskim:mentionsumls-concept:C0444186lld:lifeskim
pubmed-article:3792219lifeskim:mentionsumls-concept:C0449438lld:lifeskim
pubmed-article:3792219lifeskim:mentionsumls-concept:C0234621lld:lifeskim
pubmed-article:3792219lifeskim:mentionsumls-concept:C0441800lld:lifeskim
pubmed-article:3792219lifeskim:mentionsumls-concept:C0919553lld:lifeskim
pubmed-article:3792219lifeskim:mentionsumls-concept:C1521827lld:lifeskim
pubmed-article:3792219lifeskim:mentionsumls-concept:C1947932lld:lifeskim
pubmed-article:3792219lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:3792219pubmed:issue51-52lld:pubmed
pubmed-article:3792219pubmed:dateCreated1987-2-17lld:pubmed
pubmed-article:3792219pubmed:abstractTextFrom 923 breast cancers sent in for hormone receptor determination, 745 diagnostically utilizable Pappenheim-stained biopsy smears at 500-fold magnification were classified into eight atypia groups (1-4 without nucleoli, 5-8 with nucleoli) visually in terms of the severity of the cellular malignancy criteria. The hormone receptor status was determined with the dextran-coated charcoal method. Values from 10 fmol/mg estrogen receptor (ER) and (or) progesterone receptor (PR) content were designated as receptor-positive. There was a decrease in the proportion of receptor-positive results with increasing degree of atypia from 97% in group 2 (cases with only small nuclei without nucleoli) to 37% in group 7 (cases with multiple prominent nucleoli). When the average atypia values of subgroups were compared, the highest values were found for the 222 receptor-negative carcinomas. The marginally receptor-positive values were on average between the receptor-negative and the receptor-positive cases with high values. Both the low-ER and the low-PR have more pronounced criteria of malignancy compared to the respective high-receptor reference group.lld:pubmed
pubmed-article:3792219pubmed:languagegerlld:pubmed
pubmed-article:3792219pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3792219pubmed:citationSubsetIMlld:pubmed
pubmed-article:3792219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3792219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3792219pubmed:statusMEDLINElld:pubmed
pubmed-article:3792219pubmed:monthDeclld:pubmed
pubmed-article:3792219pubmed:issn0012-0472lld:pubmed
pubmed-article:3792219pubmed:authorpubmed-author:BurgerGGlld:pubmed
pubmed-article:3792219pubmed:authorpubmed-author:EiermannWWlld:pubmed
pubmed-article:3792219pubmed:authorpubmed-author:SchenckUUlld:pubmed
pubmed-article:3792219pubmed:authorpubmed-author:JüttingUUlld:pubmed
pubmed-article:3792219pubmed:issnTypePrintlld:pubmed
pubmed-article:3792219pubmed:day19lld:pubmed
pubmed-article:3792219pubmed:volume111lld:pubmed
pubmed-article:3792219pubmed:ownerNLMlld:pubmed
pubmed-article:3792219pubmed:authorsCompleteYlld:pubmed
pubmed-article:3792219pubmed:pagination1949-53lld:pubmed
pubmed-article:3792219pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3792219pubmed:meshHeadingpubmed-meshheading:3792219-...lld:pubmed
pubmed-article:3792219pubmed:meshHeadingpubmed-meshheading:3792219-...lld:pubmed
pubmed-article:3792219pubmed:meshHeadingpubmed-meshheading:3792219-...lld:pubmed
pubmed-article:3792219pubmed:meshHeadingpubmed-meshheading:3792219-...lld:pubmed
pubmed-article:3792219pubmed:meshHeadingpubmed-meshheading:3792219-...lld:pubmed
pubmed-article:3792219pubmed:meshHeadingpubmed-meshheading:3792219-...lld:pubmed
pubmed-article:3792219pubmed:meshHeadingpubmed-meshheading:3792219-...lld:pubmed
pubmed-article:3792219pubmed:year1986lld:pubmed
pubmed-article:3792219pubmed:articleTitle[Cytomorphological grading and hormone receptor status in breast carcinoma. Visual studies of smear preparations].lld:pubmed
pubmed-article:3792219pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3792219pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:3792219pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed